Completed PHASE1 INTERVENTIONAL 1-arm NCT01342224

Immunochemoradiotherapy in Patients With Pancreatic Cancer

Exploratory Trial of Immunochemoradiotherapy for Locally Advanced Pancreatic Adenocarcinoma

Sponsor: Providence Cancer Center, Earle A. Chiles Research Institute

Conditions Locally Advanced Pancreatic Adenocarcinoma

Updated 8 times since 2017 Last updated: Apr 10, 2018 Started: Jan 31, 2011 Primary completion: Jun 30, 2012 Completion: Apr 30, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Locally Advanced Pancreatic Adenocarcinoma and is currently completed. Providence Cancer Center, Earle A. Chiles Research Institute leads this study, which shows 8 recorded versions since 2011 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
May 2018 — Jun 2018 [monthly]

Completed PHASE1

Status: Active Not Recruiting → Completed

▶ Show 3 earlier versions

May 2017 — May 2018 [monthly]

Active Not Recruiting PHASE1
Feb 2017 — May 2017 [monthly]

Active Not Recruiting PHASE1
Jan 2017 — Feb 2017 [monthly]

Active Not Recruiting PHASE1

First recorded

Jan 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Providence Cancer Center, Earle A. Chiles Research Institute
Providence Health & Services
Robert W. Franz Cancer Research Center

Data source: Providence Health & Services

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Portland, United States